Reinvention of historic Edison complex nearly complete, as first residents move in

The long-awaited project known as Edison Village is nearing completion and already welcoming residents to its first phase: a new three-story, 34-unit building known as Edison Mews. In the coming months, Prism expects to deliver another 300 apartments when it completes its renovation and reconstruction of the 100-year-old factory complex on Main Street.

Roadway, utility upgrades underway at Prism’s ON3 campus

Prism Capital Partners has launched nearly $10 million in roadway and utility upgrades at the former Hoffmann-LaRoche campus in Nutley and Clifton, as it prepares to welcome new tenants to the 116-acre redevelopment site.

Finding new life: Young pharma, biotech firms offer second chance for New Jersey’s legacy R&D space

A growing pipeline of young life sciences firms has offered a second chance for New Jersey’s stock of legacy laboratory space. In the process, the ventures have served as anchors for developers seeking to repopulate large, vacant pharmaceutical campuses with turnkey laboratories.

Prism touts 65,000 sq. ft. in leasing at Bloomfield office park

A four-building, 380,000-square-foot office park in Bloomfield is nearing 90 percent occupancy after a flurry of new leases and renewals.

Rutgers, Monmouth students set to weigh in on Roche campus at NAIOP program

Less than a month after hosting a forum for local residents and other stakeholders, the former Hoffmann-LaRoche campus will welcome aspiring commercial real estate professionals.

High hopes for life sciences

For all the time we’ve spent highlighting New Jersey’s glut of sprawling, vacant corporate campuses, it’s easy to lose sight of just how many of them have been rescued in recent years by some of the state’s boldest and most inventive developers. Those success stories are worth telling, which is why we often do at Real Estate NJ. But there are underlying trends or nuances in some of those projects that don’t get as much attention on a day-to-day basis. Like how a crop of innovative, lesser-known biotech and pharmaceutical firms are backfilling space at the former research campuses of Sanofi and Hoffmann-LaRoche, helping to stabilize those sites as their new owners pursue larger redevelopment plans.

Hoboken project gets $120 million recap from Prism, Angelo Gordon

Angelo, Gordon & Co. and Prism Capital Partners have stepped in to help complete a plan to convert a former Wonder Bread factory in Hoboken, bringing a $120 million recapitalization to the stalled residential project.

Leasing underway at 334-unit Prism project in West Orange

Prism Capital Partners has launched leasing at its new 334-unit apartment community in West Orange, the centerpiece of what it says is the state’s largest non-waterfront adaptive-reuse project.

CBRE: Growth of pharma, biotech firms offers bright future for R&D space in N.J.

Despite years of consolidation by Big Pharma, New Jersey is one of a handful of markets that stand to gain from a promising growth trajectory for the U.S. life sciences sector.

Prism set to begin high-end office project in downtown Morristown

A rare infusion of new Class A office space is coming soon to downtown Morristown, as a developer prepares to begin a project that will deliver about 50,000 square feet to the central business district.